×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals
PR Newswire
The transaction was unanimously approved by both the AcelRx and Tetraphase Boards of Directors and is expected to close in the second quarter of...
49 months ago
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
Business Wire
--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel...
46 months ago
WilmerHale Advises Tetraphase Pharmaceuticals in Agreement to be Acquired by Melinta Therapeutics
WilmerHale
Tetraphase Pharmaceuticals, Inc. and Melinta Therapeutics announce that they have entered into a definitive merger agreement pursuant to...
46 months ago
Melinta wins bidding war to land deal to acquire Tetraphase
Fierce Biotech
Melinta Therapeutics has struck a deal to buy Tetraphase Pharmaceutica.
46 months ago
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika ...
FinancialContent
Complicated Urinary Tract Infection (cUTI) Market to Witness Growth by 2032, Estimates DelveInsight| Meiji Seika Pharma, Pfizer, Novartis,...
10 months ago
Struggling La Jolla sells out to Innoviva for $149M
Fierce Pharma
With sales of blood pressure medicine Giapreza lagging, La Jolla has sold out to royalty management company Innoviva for $149 million.
21 months ago
AcelRx Buys Tetraphase Pharma for $14.4 Million
BioSpace
AcelRx Pharmaceuticals, headquartered in Redwood City, California, is buying Watertown, Massachusetts-based TetraPhase Pharmaceuticals for...
49 months ago
Tetraphase Pharmaceuticals Announces FDA Approval of XERAVA™ (Eravacycline) for Complicated Intra-Abdominal ...
GlobeNewswire
Tetraphase's lead product, XERAVA™ (eravacycline) is FDA-approved for the treatment of complicated intra-abdominal infections (cIAI), has...
68 months ago
Bidding War Sends Tetraphase Shares Soaring
Yahoo Finance
Shares of nano-cap Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH), which have never really recovered from a steep sell-off triggered by an...
47 months ago
Tetraphase bidding war reflects antibiotic market's financial Catch-22 – analyst
S&P Global
Tetraphase bidding war reflects antibiotic market's financial Catch-22 – analyst ... A bidding war for Tetraphase Pharmaceuticals Inc. ending with...
45 months ago